BSE filing, NSE: PARNAMI. Summary written from the filing by ALFA Finder's alert engine.
QGO Finance Ltd: key numbers
- Share price
- ₹43.95
- Market cap
- ₹30.56 Cr
- Revenue (annual)
- ₹18.19 Cr
- Net profit (annual)
- ₹3.37 Cr
- P/E (TTM)
- 7.7×Sector 19.7×
- Promoter holding
- 55.47%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from QGO Finance Ltd
All →QGO Finance Board Meeting Date
QGO Finance will hold a board meeting on 30 October 2026 to approve a lock-in date revision for existing NCDs and a fresh unsecured NCD private placement. The filing is a prior intimation with proposed agenda only.
QGO Finance Management Change
QGO Finance's Company Secretary Urmi Joiser resigned to focus on her COO role. Sarita Singh was appointed in her place effective 27 October 2026.
QGO Finance Debt & Borrowing: ₹2 Cr
QGO Finance approved an issue of 200 unsecured non-convertible debentures aggregating Rs.2 Crore. The NCDs carry a 0.12 coupon payable monthly, with a 9-year tenure.
- Value
- ₹2.00 Cr
- Execution
- 9 years
QGO Finance Dividend
QGO Finance declared an interim dividend of Rs.0.15 per equity share on October 26, 2026. The record date is November 6, 2026 and the dividend period ends September 30, 2026.
QGO Finance Q2 FY27 Results: Net Profit ₹1.2 Cr, Up 50.0% YoY
QGO Finance Ltd reported revenue from operations of ₹6 Cr (+33.3% YoY) and net profit of ₹1.2 Cr (+50.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.2 Cr · +50.0% YoY
QGO Finance Board Meeting Date
QGO Finance has scheduled a board meeting for October 26, 2026, to consider financial results, a second interim dividend, and raising funds via non-convertible debentures.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.